|
|
| | Abemaciclib D5 Basic information |
| Product Name: | Abemaciclib D5 | | Synonyms: | Abemaciclib D5;N-(5-((4-(Ethyl-d5)piperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amine;2H5]-Abemaciclib;2-Pyrimidinamine, N-[5-[[4-(ethyl-1,1,2,2,2-d5)-1-piperazinyl]methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-;D5-Abemaciclib;LY2835219-d5 | | CAS: | 1809251-51-1 | | MF: | C27H27D5F2N8 | | MW: | 511.63 | | EINECS: | | | Product Categories: | | | Mol File: | 1809251-51-1.mol |  |
| | Abemaciclib D5 Chemical Properties |
| Boiling point | 689.292±65.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.325±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 7.694±0.10(predicted) |
| | Abemaciclib D5 Usage And Synthesis |
| Uses | Isotope labelled Abemaciclib is a potent and selective inhibitor of cyclin-dependent kinases, CDK4 and CDK6, as a method to inhibit the proliferation of cancer cells. |
| | Abemaciclib D5 Preparation Products And Raw materials |
|